Barclays Starts Spring Works Therapeutics (SWTX) at Overweight

May 4, 2020 5:30 PM EDT
Get Alerts SWTX Hot Sheet
Price: $72.33 +1.52%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 8 | New: 46
Trade Now! 
Join SI Premium – FREE

Barclays analyst Peter Lawson initiates coverage on Spring Works Therapeutics (NASDAQ: SWTX) with a Overweight rating and a price target of $48.00.


For an analyst ratings summary and ratings history on Spring Works Therapeutics click here. For more ratings news on Spring Works Therapeutics click here.


Shares of Spring Works Therapeutics closed at $30.21 yesterday.


You May Also Be Interested In





Related Categories

New Coverage